id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0287-0004,FDA,FDA-2005-D-0287,GUIDANCE,Supporting & Related Material,GDL-Guidance,2006-01-11T05:00:00Z,2006,1,,,2008-04-11T23:47:13Z,,0,0,0900006480445909
FDA-2005-D-0287-0003,FDA,FDA-2005-D-0287,GUIDANCE,Supporting & Related Material,GDL-Guidance,2006-01-11T05:00:00Z,2006,1,,,2008-04-11T23:47:13Z,,0,0,0900006480445907
FDA-2005-D-0287-0005,FDA,FDA-2005-D-0287,FDA,Notice,NAD-Notice of Availability of Data,2006-01-11T05:00:00Z,2006,1,2006-01-05T05:00:00Z,,2008-04-11T23:47:13Z,,0,0,090000648044590c
FDA-2005-D-0287-0001,FDA,FDA-2005-D-0287,FDA,Notice,NAD-Notice of Availability of Data,2005-12-15T05:00:00Z,2005,12,2005-12-13T05:00:00Z,,2008-04-11T23:47:13Z,,0,0,09000064804458bf
FDA-2005-D-0287-0002,FDA,FDA-2005-D-0287,Guideline,Supporting & Related Material,GDL-Guidance,2005-12-15T05:00:00Z,2005,12,,,2008-04-11T23:47:13Z,,0,0,09000064804458f7